ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Hunt, Sharon A.
  • Baker, David W.
  • Chin, Marshall H.
  • Cinquegrani, Michael P.
  • Feldman, Arthur M.
  • Francis, Gary S.
  • Ganiats, Theodore G.
  • Goldstein, Sidney
  • Gregoratos, Gabriel
  • Jessup, Mariell L.
  • Noble, R. Joseph
  • Packer, Milton
  • Silver, Marc A.
  • Stevenson, Lynne Warner
  • Gibbons, Raymond J.
  • Antman, Elliott M.
  • Alpert, Joseph S.
  • Faxon, David P.
  • Fuster, Valentin
  • Jacobs, Alice K.
  • Hiratzka, Loren F.
  • Russell, Richard O.
  • Smith, Sidney C., Jr.
    • Affiliation: School of Medicine, Department of Medicine
Abstract
  • "Heart failure (HF) is a major public health problem in the United States. Nearly 5 million patients in this country have HF, and nearly 500,000 patients are diagnosed with HF for the first time each year. The disorder is the underlying reason for 12 to 15 million office visits and 6.5 million hospital days each year (1). During the last 10 years, the annual number of hospitalizations has increased from approximately 550,000 to nearly 900,000 for HF as a primary diagnosis and from 1.7 to 2.6 million for HF as a primary or secondary diagnosis (2). Nearly 300,000 patients die of HF as a primary or contributory cause each year, and the number of deaths has increased steadily despite advances in treatment. HF is primarily a disease of the elderly (3). Approximately 6% to 10% of people older than 65 years have HF (4), and approximately 80% of patients hospitalized with HF are more than 65 years old (2). HF is the most common Medicare diagnosis-related group, and more Medicare dollars are spent for the diagnosis and treatment of HF than for any other diagnosis (5). The total inpatient and outpatient costs for HF in 1991 were approximately $38.1 billion, which was approximately 5.4% of the healthcare budget that year (1). In the United States, approximately $500 million annually is spent on drugs for the treatment of HF. The American College of Cardiology (ACC) and the American Heart Association (AHA) first published guidelines for the evaluation and management of HF in 1995 (6). Since that time, a great deal of progress has been made in the development of both pharmacological and nonpharmacological approaches to treatment for this common, costly, disabling, and generally fatal disorder. For this reason, the 2 organizations believed that the time was right to reassess and update these guidelines, fully recognizing that the optimal therapy of HF remains a work in progress and that future guidelines will supersede these."
Date of publication
Keyword
DOI
Identifier
Related resource URL
Resource type
  • Journal Item
Rights statement
  • In Copyright
Journal title
  • Journal of the American College of Cardiology
Journal volume
  • 38
Journal issue
  • 7
Page start
  • 2101
Page end
  • 2113
Language
  • English
Version
  • Postprint
ISSN
  • 0735-1097

Relations

Parents:

This work has no parents.

Items

Thumbnail Title Date Uploaded Visibility Actions
file details ACC AHA guidelines for the evaluation and management of chronic heart failure in the adult.pdf 2019-05-03 Public Download